sirolimus and Drug-Overdose

sirolimus has been researched along with Drug-Overdose* in 3 studies

Other Studies

3 other study(ies) available for sirolimus and Drug-Overdose

ArticleYear
Toxic effects of sirolimus and everolimus on the development and behavior of zebrafish embryos.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 166

    Sirolimus and everolimus have been widely used in children. These mammalian target of rapamycin (mTOR) inhibitors have shown excellent efficacy not only in organ transplant patients as immunosuppressive agents but also in patients with some other diseases. However, whether mTOR inhibitors can affect the growth and development of children is of great concern. In this study, using zebrafish models, we discovered that sirolimus and everolimus could slow the development of zebrafish, affecting indicators such as survival, hatching, deformities, body length, and movement. In addition to these basic indicators, sirolimus and everolimus had certain slowing effects on the growth and development of the nervous system, blood vessels, and the immune system. These effects were dose dependent. When the drug concentration reached or exceeded 0.5 μM, the impacts of sirolimus and everolimus were very significant. More interestingly, the impact was transient. Over time, the various manifestations of experimental embryos gradually approached those of control embryos. We also compared the effects of sirolimus and everolimus on zebrafish, and we revealed that there was no significant difference between these drugs in terms of their effects. In summary, the dose of sirolimus and everolimus in children should be strictly controlled, and the drug concentration should be monitored over time. Otherwise, drug overdosing may have a certain impact on the growth and development of children.

    Topics: Animals; Drug Overdose; Everolimus; Immunosuppressive Agents; Mammals; Sirolimus; Zebrafish

2023
Acute sirolimus overdose: a multicenter case series.
    PloS one, 2015, Volume: 10, Issue:5

    There are few data relating to sirolimus overdose in the medical literature. Our objectives were to describe all cases of overdose with sirolimus reported to Swiss, German and Austrian Poisons Centres between 2002-2013.. An observational case-series analysis was performed to determine circumstances, magnitude, management and outcome of sirolimus overdose.. Five cases of acute sirolimus overdose were reported--three in young children and two in adults. Four were accidental and one was with suicidal intent. Two patients developed symptoms probably related to sirolimus overdose: mild elevation of alkaline phosphatase, fever and gastroenteritis in a 2.5-year-old male who ingested 3 mg, and mild changes in total cholesterol in an 18-year-old female after ingestion of 103 mg. None of these events were life-threatening. Serial blood concentration measurements were performed starting 24 h after ingestion of 103 mg in a single case, and these followed a similar pharmacokinetic time-course to measurements taken after dosing in the therapeutic range.. Acute sirolimus overdose occurred accidentally in the majority of cases. Even large overdoses appeared to be well-tolerated, however children might be at greater risk of developing complications. Further study of sirolimus overdose is needed.

    Topics: Adolescent; Alkaline Phosphatase; Child, Preschool; Cholesterol; Drug Overdose; Female; Fever; Gastroenteritis; Humans; Infant; Male; Middle Aged; Retrospective Studies; Sirolimus; Suicide, Attempted

2015
Use of sirolimus in a case of severe paraquat poisoning.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:8

    Topics: Adult; Cyclophosphamide; Drug Overdose; Drug Therapy, Combination; Herbicides; Humans; Immunosuppressive Agents; Male; Paraquat; Pulmonary Fibrosis; Severity of Illness Index; Sirolimus; Steroids; Suicide, Attempted; Treatment Outcome

2008